10x Science logo

10x Science

The AI-native platform for next-generation protein characterization.

Winter 2026B2B / B2BSan Francisco, CA, USA3 employees
SaaS
B2B
Biotech
Enterprise Software
AI

About

Our mission at 10x Science is to enable biopharmaceutical development to keep pace with AI-powered drug discovery. Thanks to AI, the front end of drug discovery is flooding the pipeline with new drug candidates. However, current solutions for drug development are unable to resolve drug complexity and cannot keep up with modern demand. Our platform is the unlock for this bottleneck. By applying modern AI to the development stage, specifically to protein characterization and quality assessment, we provide an end-to-end solution to dramatically speed up and scale up the preparation of candidates for the clinic. Our team is composed of Stanford University researchers from a Nobel Laureate's lab with 18+ years of collective domain expertise, 47+ scientific publications, and a 2x YC Founder. We move at the highest velocity and are positioned to lead the next-generation of modern AI drug development.

Founders (3)

David Roberts
Founder and CEO
Andrew Reiter
Founder and COO
Vishnu Tejus
Founder and CTO

Details

Status
Active
Stage
Early
Team Size
3
Regions
United States of America, America / Canada, Remote, Partly Remote